GÜMÜŞLÜ, S. Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions. Congress of the European Academy of Allergy and Clinical Immunology (EAACI) , (İstanbul, Turkey), 154.

GÜMÜŞLÜ, S., Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions . Congress of the European Academy of Allergy and Clinical Immunology (EAACI) (pp.154). İstanbul, Turkey

GÜMÜŞLÜ, SAADET. "Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions," Congress of the European Academy of Allergy and Clinical Immunology (EAACI), İstanbul, Turkey,

GÜMÜŞLÜ, SAADET. "Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions." Congress of the European Academy of Allergy and Clinical Immunology (EAACI) , İstanbul, Turkey, pp.154

GÜMÜŞLÜ, S. . "Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions." Congress of the European Academy of Allergy and Clinical Immunology (EAACI) , İstanbul, Turkey, p.154.

@conferencepaper{conferencepaper, author={SAADET GÜMÜŞLÜ}, title={Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions}, congress name={Congress of the European Academy of Allergy and Clinical Immunology (EAACI)}, city={İstanbul}, country={Turkey}, year={0}, pages={154} }